Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairs
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference38 articles.
1. Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants;Bhagchandani;Adv Drug Deliv Rev,2021
2. Structural analyses of toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands;Zhang;Cell Reports,2018
3. TLR8 activation and inhibition by guanosine analogs in RNA: Importance of functional groups and chain length;Hu;Bioorg Med Chem,2018
4. Latest advances in small molecule TLR 7/8 agonist drug research;David;Curr Top Med Chem,2019
5. Synthesis and structure–activity-relationships of 1H-Imidazo[4,5-c]quinolines that induce interferon production;Gerster;J Med Chem,2005
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID;International Journal of Molecular Sciences;2024-07-12
2. Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies;Biomedicine & Pharmacotherapy;2023-03
3. Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG;ACS Infectious Diseases;2023-02-21
4. Recent Advances on Small-Molecule Antagonists Targeting TLR7;Molecules;2023-01-07
5. Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits;Journal of Medicinal Chemistry;2022-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3